Rankings
▼
Calendar
PHIO Q2 2021 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-21.46
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$132,000
Balance Sheet
Total Assets
$32M
Total Liabilities
$3M
Stockholders' Equity
$29M
Cash & Equivalents
$29M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$779,000
+100.0%
Operating Income
-$3M
-$2M
-60.8%
Net Income
-$3M
-$2M
-60.7%
← FY 2021
All Quarters
Q3 2021 →